BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16618381)

  • 1. Multimodality treatment of esophageal cancer: a review of the current status and future directions.
    Ng T; Dipetrillo T; Purviance J; Safran H
    Curr Oncol Rep; 2006 May; 8(3):174-82. PubMed ID: 16618381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
    Shinoda M; Hatooka S; Mori S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H
    Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
    Iyer R; Wilkinson N; Demmy T; Javle M
    Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
    Hoeppner J; Lordick F; Brunner T; Glatz T; Bronsert P; Röthling N; Schmoor C; Lorenz D; Ell C; Hopt UT; Siewert JR
    BMC Cancer; 2016 Jul; 16():503. PubMed ID: 27435280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality therapy in esophageal cancer: the Memorial experience.
    Anderson SE; Minsky BD; Bains M; Kelsen DP; Ilson DH
    Semin Surg Oncol; 2003; 21(4):228-32. PubMed ID: 14648780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined-modality therapy for locoregional esophageal cancer].
    Kim SB
    Korean J Gastroenterol; 2004 Oct; 44(4):179-85. PubMed ID: 15505428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
    Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
    Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy of esophageal cancer--standard of care?
    Urba S
    Surg Oncol Clin N Am; 2002 Apr; 11(2):377-86. PubMed ID: 12424857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality therapy of local regional esophageal cancer.
    Kelsen DP
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
    Mooney MM
    J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of multimodality therapy for esophageal cancer.
    Krasna MJ; Tepper J
    Chest Surg Clin N Am; 2000 Aug; 10(3):591-603. PubMed ID: 10967760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care?
    Schneider BJ; Urba SG
    Semin Radiat Oncol; 2007 Jan; 17(1):45-52. PubMed ID: 17185197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of localized esophageal cancer.
    Brenner B; Ilson DH; Minsky BD
    Semin Oncol; 2004 Aug; 31(4):554-65. PubMed ID: 15297946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H; Blewett CJ
    Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.